⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20089278 | 0.74 | — | — | |
| SCHEMBL19929744 | 0.69 | EPAS1 (0.35) | — | |
| SCHEMBL19929739 | 0.69 | EPAS1 (0.32) | — | |
| SCHEMBL8591968 | 0.69 | — | — | |
| SCHEMBL5046288 | 0.69 | — | — | |
| SCHEMBL129851 | 0.69 | — | — | |
| SCHEMBL5043610 | 0.69 | — | — | |
| SCHEMBL14988855 | 0.68 | — | — | |
| SCHEMBL19929741 | 0.68 | MEN1 (0.31) | — | |
| SCHEMBL18105114 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7361668-B2 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | UCB, S.A. (BE) | 2008-04-22 | — | — | US | disclosed |
| US-20050020660-A1 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | UCB, S.A. (BE) | 2005-01-27 | — | — | US | disclosed |